Clinical Trial Update: A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effectiveness and safety of Ozanimod in Chinese adults with relapsing multiple sclerosis; the study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Ozanimod (ozanimod)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Relapsing Multiple Sclerosis | Phase 4 | Status: ACTIVE_NOT_RECRUITING